Literature DB >> 12441104

Insights into Lou Gehrig's disease from the structure and instability of the A4V mutant of human Cu,Zn superoxide dismutase.

Rosa M F Cardoso1, Maria M Thayer, Michael DiDonato, Terence P Lo, Cami K Bruns, Elizabeth D Getzoff, John A Tainer.   

Abstract

Mutations in human superoxide dismutase (HSOD) have been linked to the familial form of amyotrophic lateral sclerosis (FALS). Amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) is one of the most common neurodegenerative disorders in humans. In ALS patients, selective killing of motor neurons leads to progressive paralysis and death within one to five years of onset. The most frequent FALS mutation in HSOD, Ala4-->Val, is associated with the most rapid disease progression. Here we identify and characterize key differences in the stability between the A4V mutant protein and its thermostable parent (HSOD-AS), in which free cysteine residues were mutated to eliminate interferences from cysteine oxidation. Denaturation studies reveal that A4V unfolds at a guanidine-HCl concentration 1M lower than HSOD-AS, revealing that A4V is significantly less stable than HSOD-AS. Determination and analysis of the crystallographic structures of A4V and HSOD-AS reveal structural features likely responsible for the loss of architectural stability of A4V observed in the denaturation experiments. The combined structural and biophysical results presented here argue that architectural destabilization of the HSOD protein may underlie the toxic function of the many HSOD FALS mutations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12441104     DOI: 10.1016/s0022-2836(02)01090-2

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  26 in total

1.  A possible therapeutic target for Lou Gehrig's disease.

Authors:  Soumya S Ray; Peter T Lansbury
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-12       Impact factor: 11.205

2.  Structural consequences of the familial amyotrophic lateral sclerosis SOD1 mutant His46Arg.

Authors:  Svetlana Antonyuk; Jennifer Stine Elam; Michael A Hough; Richard W Strange; Peter A Doucette; Jorge A Rodriguez; Lawrence J Hayward; Joan Selverstone Valentine; P John Hart; S Samar Hasnain
Journal:  Protein Sci       Date:  2005-05       Impact factor: 6.725

3.  Molecular characterization of two superoxide dismutases from Hydra vulgaris.

Authors:  Bhagirathi Dash; Richard Metz; Henry J Huebner; Weston Porter; Timothy D Phillips
Journal:  Gene       Date:  2006-09-12       Impact factor: 3.688

4.  Contribution of human manganese superoxide dismutase tyrosine 34 to structure and catalysis.

Authors:  J Jefferson P Perry; Amy S Hearn; Diane E Cabelli; Harry S Nick; John A Tainer; David N Silverman
Journal:  Biochemistry       Date:  2009-04-21       Impact factor: 3.162

5.  A common property of amyotrophic lateral sclerosis-associated variants: destabilization of the copper/zinc superoxide dismutase electrostatic loop.

Authors:  Kathleen S Molnar; N Murat Karabacak; Joshua L Johnson; Qi Wang; Ashutosh Tiwari; Lawrence J Hayward; Stephen J Coales; Yoshitomo Hamuro; Jeffrey N Agar
Journal:  J Biol Chem       Date:  2009-07-27       Impact factor: 5.157

Review 6.  The structural biochemistry of the superoxide dismutases.

Authors:  J J P Perry; D S Shin; E D Getzoff; J A Tainer
Journal:  Biochim Biophys Acta       Date:  2009-11-13

7.  Cis-suppression to arrest protein aggregation in mammalian cells.

Authors:  Simpson Gregoire; Shaojie Zhang; Joseph Costanzo; Kelly Wilson; Erik J Fernandez; Inchan Kwon
Journal:  Biotechnol Bioeng       Date:  2013-10-18       Impact factor: 4.530

8.  Aggregation propensities of superoxide dismutase G93 hotspot mutants mirror ALS clinical phenotypes.

Authors:  Ashley J Pratt; David S Shin; Gregory E Merz; Robert P Rambo; W Andrew Lancaster; Kevin N Dyer; Peter P Borbat; Farris L Poole; Michael W W Adams; Jack H Freed; Brian R Crane; John A Tainer; Elizabeth D Getzoff
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-14       Impact factor: 11.205

9.  Altered thiol chemistry in human amyotrophic lateral sclerosis-linked mutants of superoxide dismutase 1.

Authors:  Carles Solsona; Thomas B Kahn; Carmen L Badilla; Cristina Álvarez-Zaldiernas; Juan Blasi; Julio M Fernandez; Jorge Alegre-Cebollada
Journal:  J Biol Chem       Date:  2014-08-04       Impact factor: 5.157

10.  Cu/Zn superoxide dismutase mutants associated with amyotrophic lateral sclerosis show enhanced formation of aggregates in vitro.

Authors:  P B Stathopulos; J A O Rumfeldt; G A Scholz; R A Irani; H E Frey; R A Hallewell; J R Lepock; E M Meiering
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.